MedPath

PRZ-OLMESARTAN/HCTZ

PRZ-OLMESARTAN/HCTZ

Dormant
DIN Number

02526476

Drug Class

Human

Market Date

Oct 4, 2022

Company
HC

pharmaris canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02526476
AIG Number0252502002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA08 OLMESARTAN MEDOXOMIL AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE
OLMESARTAN MEDOXOMILActive
Strength: 40 MG
Monograph: OLMESARTAN MEDOXOMIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.